https://scholars.lib.ntu.edu.tw/handle/123456789/586168
標題: | Novel App-Based Portable Spirometer for the Early Detection of COPD | 作者: | Lin, Ching-Hsiung Cheng, Shih-Lung HAO-CHIEN WANG Hsu, Wu-Huei Lee, Kang-Yun Perng, Diahn-Warng Lin, Hen-I Lin, Ming-Shian Tsai, Jong-Rung Wang, Chin-Chou Lin, Sheng-Hao Wang, Cheng-Yi Chen, Chiung-Zuei Yang, Tsung-Ming Liu, Ching-Lung Wang, Tsai-Yu Lin, Meng-Chih |
關鍵字: | COPD; app-based spirometer; early detection; underdiagnosis | 公開日期: | 27-四月-2021 | 卷: | 11 | 期: | 5 | 來源出版物: | Diagnostics (Basel, Switzerland) | 摘要: | Chronic obstructive pulmonary disease (COPD) is preventable and treatable. However, many patients remain undiagnosed and untreated due to the underutilization or unavailability of spirometers. Accordingly, we used Spirobank Smart, an app-based spirometer, for facilitating the early detection of COPD in outpatient clinics. This prospective study recruited individuals who were at risk of COPD (i.e., with age of ≥40 years, ≥10 pack-years of smoking, and at least one respiratory symptoms) but had no previous COPD diagnosis. Eligible participants were examined with Spirobank Smart and then underwent confirmatory spirometry (performed using a diagnostic spirometer), regardless of their Spirobank Smart test results. COPD was defined and confirmed using the postbronchodilator forced expiratory volume in 1 s/forced vital capacity values of <0.70 as measured by confirmatory spirometry. A total of 767 participants were enrolled and examined using Spirobank Smart; 370 participants (94.3% men, mean age of 60.9 years and mean 42.6 pack-years of smoking) underwent confirmatory spirometry. Confirmatory spirometry identified COPD in 103 participants (27.8%). At the optimal cutoff point of 0.74 that was determined using Spirobank Smart for COPD diagnosis, the area under the receiver operating characteristic was 0.903 (95% confidence interval (CI) = 0.860-0.947). Multivariate logistic regression revealed that participants who have an FEV1/FVC ratio of <74% that was determined using Spirobank Smart (odds ratio (OR) = 58.58, 95% CI = 27.29-125.75) and old age (OR = 3.23, 95% CI = 1.04-10.07 for 60 ≤ age < 65; OR = 5.82, 95% CI = 2.22-15.27 for age ≥ 65) had a higher risk of COPD. The Spirobank Smart is a simple and adequate tool for early COPD detection in outpatient clinics. Early diagnosis and appropriate therapy based on GOLD guidelines can positively influence respiratory symptoms and quality of life. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/586168 | ISSN: | 2075-4418 | DOI: | 10.3390/diagnostics11050785 | SDG/關鍵字: | bronchodilating agent; adult; aged; Article; body mass; bronchodilatation; chronic obstructive lung disease; controlled study; disease severity; early diagnosis; female; forced expiratory volume; forced vital capacity; human; lung function; major clinical study; male; middle aged; mobile application; multicenter study; outpatient department; predictive value; prospective study; quality of life; receiver operating characteristic; reference value; respiratory tract disease; sensitivity and specificity; smoking; spirometry; validation study |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。